Artificial bile ducts grown in lab & transplanted into mice could help treat liver disease
(University of Cambridge) Cambridge scientists have developed a new method for growing and transplanting artificial bile ducts that could in future be used to help treat liver disease in children, reducing the need for liver transplantation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2017 Category: International Medicine & Public Health Source Type: news
Singapore scientists uncover how the liver unclogs itself
This study was published online in the Journal of Hepatology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 30, 2017 Category: Biology Source Type: news
Raw fish dishes in Thailand are full of deadly parasites
One of the major causes of bile duct cancer, which kills 20,000 Thais each year, is a parasitic flatworm native to the Mekong region and found in freshwater fish. (Source: the Mail online | Health)
Source: the Mail online | Health - June 28, 2017 Category: Consumer Health News Source Type: news
Avoid raw fish dishes during your holiday in Thailand!
One of the major causes of bile duct cancer, which kills 20,000 Thais each year, is a parasitic flatworm native to the Mekong region and found in freshwater fish. (Source: the Mail online | Health)
Source: the Mail online | Health - June 28, 2017 Category: Consumer Health News Source Type: news
How bile duct cancer develops and how it can be prevented
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) What promotes the development of bile duct cancer in the liver? Are these factors different from those that are responsible for the much more common hepatocellular carcinomas? Scientists from the Heidelberg and Munich have been the first to uncover the molecular causes that selectively lead to the development of bile duct cancer in mice. The researchers also discovered that antioxidants or an inhibitor of a specific key enzyme can be used to stop this cancer-promoting process. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2017 Category: Cancer & Oncology Source Type: news
Rose Hip and Heart Disease
This study features the use of ourABCA1 Antibody. The ATP-binding cassette transporter (ABC) Protein called ABCA1 has a major impact on cellular and whole body cholesterol metabolism and is likely to play an important role in protecting against cardiovascular disease.The authors conclude that rose hip is a suitable dietary supplement for preventing atherosclerotic plaques formation by modulating systemic blood pressure and the expression of RCT and inflammatory genes.Michele Cavalera, Ulrika Axling, Catarina Rippe, Karl Sw ärd, and Cecilia Holm. Dietary rose hip exerts anti-atherosclerotic effects and increases nitric oxi...
Source: Neuromics - May 30, 2017 Category: Neuroscience Tags: ABCA1 atherosclerosis Blood Pressure cholestrol metabolism heart Source Type: news
Extracellular Vesicles in Bile Promising Biomarker for Malignant Biliary Stenoses Extracellular Vesicles in Bile Promising Biomarker for Malignant Biliary Stenoses
The concentration of extracellular vesicles (EVs) in bile can be used as a biomarker to differentiate malignant from nonmalignant common bile duct stenoses, researchers report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 26, 2017 Category: Pathology Tags: Gastroenterology News Source Type: news
Updated Guideline on Management of Common Bile Duct Stones Updated Guideline on Management of Common Bile Duct Stones
This article presents the most up-to-date recommendations.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 25, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
Title: Chemo Drug May Buy Time for Those With Bile Duct CancerCategory: Health NewsCreated: 5/18/2017 12:00:00 AMLast Editorial Review: 5/19/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 19, 2017 Category: Cancer & Oncology Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 18, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Nursing, Oncology, News, Source Type: news
Chemo Drug May Buy Time for Those with Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say Source: HealthDay Related MedlinePlus Pages: Bile Duct Cancer, Cancer Chemotherapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 18, 2017 Category: Consumer Health News Source Type: news
Chemo Drug, Xeloda, May Buy Time for Those With Bile Duct Cancer
THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2017 Category: General Medicine Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2017 Category: General Medicine Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say (Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - May 18, 2017 Category: Cancer & Oncology Source Type: news
Capecitabine improves post-surgery survival period in bile duct cancer patients
A Cancer Research UK-funded trial (BILCAP) showed that the chemotherapy drug capecitabine increased the survival period of bile duct cancer patients by up to one and a half years after undergoing surgery for the disease. (Source: Drug Development Technology)
Source: Drug Development Technology - May 17, 2017 Category: Pharmaceuticals Source Type: news
